EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of naked pDNA inhalation powder formulation with high transfection efficiency using hyaluronic acid and phenylalanine as excipients

Takaaki Ito, Tomoyuki Okuda, Seiko Uede, Yuki Kushi, Kohei Tahara, Hirokazu Okamoto

Advanced Powder Technology · 2025-01 · 36 (1) · 104750

DOI: 10.1016/j.apt.2024.104750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Powder Technology, 2025-01. Verfasst von Takaaki Ito und 5 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pharmaceutical Society of Japan, Japan Society for the Promotion of Science.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

• We developed excipient combinations for inhaled naked plasmid DNA powders. • Phenylalanine and hyaluronic acid are suitable in combination as excipients. • The combination ratio determines transfection efficiency and aerosol performance. • Phenylalanine improves aerosol performance as a dispersion enhancer. • The molecular weight of hyaluronic acid influences transfection efficiency. Nucleic acid-based inhalational drugs hold great clinical promise, but development has been limited by poor transfection efficiency among other factors. We previously described a plasmid (p)DNA powder without vector (naked pDNA powder) prepared for inhalation by spray-freeze-drying and containing hyaluronic acid (HA) as an excipient that demonstrated high transfection efficiency in the lungs. In the present study, we describe modified formulations in which HA is partially replaced by hydrophobic amino acids to enhance dispersibility in air and HA molecular weight is optimized for greater transfection efficiency. In vivo experiments in mice revealed that L-phenylalanine (Phe) in combination with HA conferred higher transfection efficiency than other hydrophobic amino acids. Furthermore, both in vivo and in vitro assays demonstrated that 50 kDa HA conferred higher transfection efficiency than other molecular weights and that the naked pDNA powder composed of 73% HA (50 kDa) and 25% Phe yielded the highest transfection efficiency among powders investigated. A higher relative Phe ratio enhanced aerosol performance but yielded lower transfection efficiency. This trade-off highlights the importance of comprehensively evaluating inhalational powders for both intrinsic transfection efficiency and aerosol performance.

Förderung

  • Pharmaceutical Society of Japan
  • Japan Society for the Promotion of Science

Zitieren

APA

Ito, T., Okuda, T., Uede, S., Kushi, Y., Tahara, K., & Okamoto, H. (2025). Development of naked pDNA inhalation powder formulation with high transfection efficiency using hyaluronic acid and phenylalanine as excipients. Advanced Powder Technology, 36(1), 104750. https://doi.org/10.1016/j.apt.2024.104750

Vancouver

Ito T, Okuda T, Uede S, Kushi Y, Tahara K, Okamoto H. Development of naked pDNA inhalation powder formulation with high transfection efficiency using hyaluronic acid and phenylalanine as excipients. Advanced Powder Technology. 2025;36(1):104750. doi:10.1016/j.apt.2024.104750

BibTeX
@article{Ito2025,
  author = {Ito, Takaaki and Okuda, Tomoyuki and Uede, Seiko and Kushi, Yuki and Tahara, Kohei and Okamoto, Hirokazu},
  title = {Development of naked pDNA inhalation powder formulation with high transfection efficiency using hyaluronic acid and phenylalanine as excipients},
  journal = {Advanced Powder Technology},
  year = {2025},
  volume = {36},
  number = {1},
  pages = {104750},
  doi = {10.1016/j.apt.2024.104750}
}
Kostenlos starten →